Article

Treatment With Oral Anticancer Agents: Symptom Severity and Attribution, and Interference With Comorbidity Management

Barbara A. Given

Charles Given

Atreyee Majumder

age, symptom severity, cancer, oncology, strategies, intervention, comorbid condition, attribution, oral agent, oral anticancer agent
ONF 2015, 42(1), 80-88. DOI: 10.1188/15.ONF.42-01P

Purpose/Objectives: To evaluate the prevalence, severity, and attribution of symptoms, as well as the interference with management of comorbidities, in patients who have been prescribed oral anticancer agents (OAs).

Design: Descriptive exploratory study.

Setting: A comprehensive cancer center and two community-based oncology programs in the midwestern United States.

Sample: 30 adults undergoing OA treatment.

Methods: Five phone interviews were conducted during eight weeks. Linear mixed effects and generalized estimating equations were used to examine symptoms and interference over time.

Main Research Variables: Symptoms and comorbid conditions.

Findings: The mean age of participants was 65.1 years. Fifteen participants were female, 25 were Caucasian, and 23 had comorbidities. Twenty-one patients had late-stage cancer, and rates of adherence were 90%. Fatigue, sleep disturbance, and numbness or tingling in hands and feet were highly prevalent symptoms. Younger age was associated with higher symptom severity (p < 0.01) and interference (p = 0.01). Patients with more comorbidities tended to report higher symptom severity. Simultaneous IV chemotherapy was not a predictor of symptom severity or interference over age and comorbidity. Symptoms were most frequently attributed to cancer and its treatment. Patients with a greater number of comorbidities were more likely to include comorbidities in symptom attribution and reported interference from the OA with managing comorbid conditions.

Conclusions: Symptoms may be more severe in patients prescribed OAs who are younger and have comorbid conditions. More comorbidities and absence of simultaneous IV chemotherapy increased the likelihood of inclusion of chronic conditions in symptom attribution. Patients reported that OA treatment interfered with comorbidity management.

Implications for Nursing: Nurses need to take comorbidities into account when caring for patients prescribed OAs because the chronic conditions may influence symptom severity and the ability to manage symptoms.

Jump to a section

    References

    Accordino, M. K., & Hershman, D. L. (2013). Disparities and challenges in adherence to oral antineoplastic agents. American Society of Clinical Oncology Educational Book, 2013, 271-276. doi:10.1200/EdBook_AM.2013.33.271
    Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall.
    Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191-215.
    Bassan, F., Peter, F., Houbre, B., Brennstuhl, M. J., Costantini, M., Speyer, E., & Tarquinio, C. (2014). Adherence to oral antineoplastic agents by cancer patients: Definition and literature review. European Journal of Cancer Care, 23, 22-35. doi:10.1111/ecc.12124
    Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2005). Subjective assessments of comorbidity correlate with quality of life health outcomes: Initial validation of a comorbidity assessment instrument. Health and Quality of Life Outcomes, 3, 51. doi:10.1186/1477-7525-3-51
    Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2007). Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Annals of Family Medicine, 5, 395-402. doi:10.1370/afm.722
    Bayliss, E. A., Steiner, J. F., Fernald, D. H., Crane, L. A., & Main, D. S. (2003). Descriptions of barriers to self-care by persons with comorbid chronic diseases. Annals of Family Medicine, 1, 15-21. doi:10.1370/afm.4
    Bender, C. M., Engberg, S. J., Donovan, H. S., Cohen, S. M., Houze, M. P., Rosenzweig, M. Q., … Sereika, S. M. (2008). Symptom clusters in adults with chronic health problems and cancer as a comorbidity [Online exclusive]. Oncology Nursing Forum, 35, E1-E11. doi:10.1188/08.ONF.E1-E11
    Brant, J. M. (2008). Symptom trajectories in patients with lung cancer, colorectal cancer, and lymphoma during chemotherapy and posttreatment: A latent growth curve analysis. (Doctoral dissertation). University of Utah, Salt Lake City.
    Cella, D. P., Yount, S. P., Rothrock, N. P., Gershon, R. P., Cook, K. P., Reeve, B. P., … Rose, M. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45, S3-S11. doi:10.1097/01.mlr.0000258615.42478.55
    Chrischilles, E. A., Pendergast, J. F., Kahn, K. L., Wallace, R. B., Moga, D. C., Harrington, D. P., … Fletcher, R. H. (2010). Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. Journal of Clinical Oncology, 28, 620-627. doi:10.1200/JCO.2009.23.8485
    Chu, Y. T., Ng, Y. Y., & Wu, S. C. (2010). Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Services Research, 10, 140. doi:10.1186/1472-6963-10-140
    Cleeland, C. S., Sloan, J. A., Cella, D., Chen, C., Dueck, A. C., Janjan, N. A., … Woodruff, J. F. (2013). Recommendations for including multiple symptoms as endpoints in cancer clinical trials: A report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer, 119, 411-420. doi:10.1002/cncr.27744
    Cleeland, C. S., Zhao, F., Chang, V. T., Sloan, J. A., O'Mara, A. M., Gilman, P. B., … Fisch, M. J. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer, 119, 4333-4340. doi:10.1002/cncr.28376
    Deimling, G. T., Arendt, J. A., Kypriotakis, G., & Bowman, K. F. (2009). Functioning of older, long-term cancer survivors: The role of cancer and comorbidities. Journal of the American Geriatrics Society, 57, S289-S292. doi:10.1111/j.1532-5415.2009.02515.x
    Deshields, T. L., Potter, P., Olsen, S., Liu, J., & Dye, L. (2011). Documenting the symptom experience of cancer patients. Journal of Supportive Oncology, 9, 216-223. doi:10.1016/j.suponc.2011.06.003
    Findlay, M., von Minckwitz, G., & Wardley, A. (2008). Effective oral chemotherapy for breast cancer: Pillars of strength. Annals of Oncology, 19, 212-222. doi:10.1093/annonc/mdm285
    Given, B., Given, C. W., Sikorskii, A., Jeon, S., McCorkle, R., Champion, V., & Decker, D. (2008). Establishing mild, moderate, and severe scores for cancer related symptoms: How consistent and clinically meaningful are interference based severity cut points? Journal of Pain and Symptom Management, 35, 126-135. doi:10.1016/j.jpainsymman.2007.03.012
    Given, B. A., Spoelstra, S. L., & Grant, M. (2011). The challenges of oral agents as antineoplastic treatments. Seminars in Oncology Nursing, 27, 93-103. doi:10.1016/j.soncn.2011.02.003
    Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. Journal of Pain and Symptom Management, 21, 456-466. doi:10.1016/S0885-3924(01)00284-6
    Given, C. W., Given, B. A., Sikorskii, A., You, M., Jeon, S., Champion, V., & McCorkle, R. (2010). Deconstruction of nurse-delivered patient self-management interventions for symptom management: Factors related to delivery enactment and response. Annals of Behavioral Medicine, 40, 99-113. doi:10.1007/s12160-010-9191-7
    Glasgow, R. E. (2007). Perceived barriers to self-management and preventive behaviors. Retrieved from http://1.usa.gov/1rcsQhL
    Henoch, I., & Lövgren, M. (2014). The influence of symptom clusters and the most distressing concerns regarding quality of life among patients with inoperable lung cancer. European Journal of Oncology Nursing, 18, 236-241. doi:10.1016/j.ejon.2013.12.001
    Hillman, S. L., Mandrekar, S. J., Bot, B., DeMatteo, R. P., Perez, E. A., Ballman, K. V., … Sargent, D. J. (2010). Evaluation of the value of attribution in the interpretation of adverse event data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation. Journal of Clinical Oncology, 28, 3002-3007. doi:10.1200/JCO.2009.27.4282
    Hurria, A. (2011). Embracing the complexity of comorbidity. Journal of Clinical Oncology, 29, 4217-4218. doi:10.1200/JCO.2011.37.5717
    Hurria, A., Hurria, A., Brogan, K., Panageas, K. S., Pearce, C., Norton, L., … Hudis, C. (2005). Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer. Drugs and Aging, 22, 785-791.
    Hurria, A., Hurria, A., Zuckerman, E., Panageas, K. S., Fornier, M., D'Andrea, G., … Hudis, C. (2006). A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. Journal of the American Geriatrics Society, 54, 1119-1124.
    Hurria, A., Wildes, T., Blair, S. L., Browner, I. S., Cohen, H. J., deShazo, M., … Sundar, H. (2014). Senior Adult Oncology, Version 2.2014: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 12, 82-126.
    Hurria, A., Wong, F. L., Villaluna, D., Bhatia, S., Chung, C. T., Mortimer, J., … Naeim, A. (2008). Role of age and health in treatment recommendations for older adults with breast cancer: The perspective of oncologists and primary care providers. Journal of Clinical Oncology, 26, 5386-5392. doi:10.1200/JCO.2008.17.6891
    Kahana, B., Kahana, E., Deimling, G., Sterns, S., & VanGunten, M. (2011). Determinants of altered life perspectives among older-adult long-term cancer survivors. Cancer Nursing, 34, 209-218. doi:10.1097/NCC.0b013e3181fa56b0
    Kerr, E. A., Heisler, M., Krein, S. L., Kabeto, M., Langa, K. M., Weir, D., & Piette, J. D. (2007). Beyond comorbidity counts: How do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? Journal of General Internal Medicine, 22, 1635-1640. doi:10.1007/s11606-007-0313-2
    Koroukian, S. M., Murray, P., & Madigan, E. (2006). Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. Journal of Clinical Oncology, 24, 2304-2310. doi:10.1200/JCO.2005.03.1567
    Lee, L., Cheung, W. Y., Atkinson, E., & Krzyzanowska, M. K. (2011). Impact of comorbidity on chemotherapy use and outcomes in solid tumors: A systematic review. Journal of Clinical Oncology, 29, 106-117. doi:10.1200/JCO.2010.31.3049
    McCorkle, R., Ercolano, E., Lazenby, M., Schulman-Green, D., Schilling, L. S., Lorig, K., & Wagner, E. H. (2011). Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA: A Cancer Journal for Clinicians, 61, 50-62. doi:10.3322/caac.20093
    Molassiotis, A., Brearley, S., Saunders, M., Craven, O., Wardley, A., Farrell, C., … Luker, K. (2009). Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: A randomized, controlled trial. Journal of Clinical Oncology, 27, 6191-6198. doi:10.1200/JCO.2008.20.6755
    Pal, S. K., & Hurria, A. (2010). Impact of age, sex, and comorbidity on cancer therapy and disease progression. Journal of Clinical Oncology, 28, 4086-4093. doi:10.1200/JCO.2009.27.0579
    Peperstraete, B. (2013). Management of comorbidities in heart failure. Revue Médicale de Bruxelles, 34, 154-162.
    Phipps, E., Braitman, L. E., Stites, S., & Leighton, J. C. (2008). Quality of life and symptom attribution in long-term colon cancer survivors. Journal of Evaluation in Clinical Practice, 14, 254-258.
    Piette, J. D., & Kerr, E. A. (2006). The impact of comorbid chronic conditions on diabetes care. Diabetes Care, 29, 725-731. doi:10.2337/diacare.29.03.06.dc05-2078
    Puts, M. T., Tu, H. A., Tourangeau, A., Howell, D., Fitch, M., Springall, E., & Alibhai, S. M. (2013). Factors influencing adherence to cancer treatment in older adults with cancer: A systematic review. Annals of Oncology, 25, 564-577. doi:10.1093/annonc/mdt433
    Reyes-Gibby, C. C., Aday, L. A., Anderson, K. O., Mendoza, T. R., & Cleeland, C. S. (2006). Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. Journal of Pain and Symptom Management, 32, 118-128. doi:10.1016/j.jpainsymman.2006.01.008
    Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2, 328-335.
    Siegel, K., Lekas, H. M., & Maheshwari, D. (2012). Causal attributions for fatigue by older adults with advanced cancer. Journal of Pain and Symptom Management, 44, 52-63. doi:10.1016/j.jpainsymman.2011.07.013
    Sikorskii, A., Given, C. W., Given, B., Jeon, S., Decker, V., Decker, D., … McCorkle, R. (2007). Symptom management for cancer patients: A trial comparing two multimodal interventions. Journal of Pain and Symptom Management, 34, 253-264. doi:10.1016/j.jpainsymman.2006.11.018
    Sikorskii, A., Given, C. W., Siddiqi, A. E., Champion, V., McCorkle, R., Spoelstra, S. L., & Given, B. A. (2014). Testing the differential effects of symptom management interventions in cancer. Psycho-Oncology. Advance print publication. doi:10.1002/pon.3555
    Sommers, R. M., Miller, K., & Berry, D. L. (2012). Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer [Online exclusive]. Oncology Nursing Forum, 39, E373-E379. doi:10.1188/12.ONF.E373-E379
    Soria, J. C., Blay, J. Y., Spano, J. P., Pivot, X., Coscas, Y., & Khayat, D. (2011). Added value of molecular targeted agents in oncology. Annals of Oncology, 22, 1703-1716. doi:10.1093/annonc/mdq675
    Spoelstra, S. L., Given, B. A., Given, C. W., Grant, M., Sikorskii, A., You, M., & Decker, V. (2013a). An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: An exploratory study. Cancer Nursing, 36, 18-28. doi:10.1097/NCC.0b013e3182551587
    Spoelstra, S. L., Given, B. A., Given, C. W., Grant, M., Sikorskii, A., You, M., & Decker, V. (2013b). Issues related to overadherence to oral chemotherapy or targeted agents. Clinical Journal of Oncology Nursing, 17, 604-609. doi:10.1188/13.CJON.17-06AP
    Spoelstra, S. L., & Given, C. W. (2011). Assessment and measurement of adherence to oral antineoplastic agents. Seminars in Oncology Nursing, 27, 116-132. doi:10.1016/j.soncn.2011.02.004
    Sullivan, P. W., Ghushchyan, V. H., & Bayliss, E. A. (2012). The impact of co-morbidity burden on preference-based health-related quality of life in the United States. PharmacoEconomics, 30, 431-442. doi:10.2165/11586840-000000000-00000
    Weingart, S. N., Brown, E., Bach, P. B., Eng, K., Johnson, S. A., Kuzel, T. M., … Walters, R. S. (2008). NCCN Task Force Report: Oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6, S1-S14.
    Weingart, S. N., Spencer, J., Buia, S., Duncombe, D., Singh, P., Gadkari, M., & Connor, M. (2011). Medication safety of five oral chemotherapies: A proactive risk assessment. Journal of Oncology Practice, 7, 2-6. doi:10.1200/JOP.2010.000064
    Winkeljohn, D. (2010). Adherence to oral cancer therapies: Nursing interventions. Clinical Journal of Oncology Nursing, 14, 461-466. doi:10.1188/10.CJON.461-466
    Yamagishi, A., Morita, T., Miyashita, M., & Kimura, F. (2009). Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. Journal of Pain and Symptom Management, 37, 823-830. doi:10.1016/j.jpainsymman.2008.04.015